PSOAX
Price
$26.28
Change
+$0.17 (+0.65%)
Updated
Sep 26 closing price
Net Assets
1.25B
UBVVX
Price
$86.07
Change
+$0.94 (+1.10%)
Updated
Sep 26 closing price
Net Assets
9.84B
Interact to see
Advertisement

PSOAX vs UBVVX

Header iconPSOAX vs UBVVX Comparison
Open Charts PSOAX vs UBVVXBanner chart's image
JPMorgan Small Cap Value A
Price$26.28
Change+$0.17 (+0.65%)
VolumeN/A
Net Assets1.25B
Undiscovered Managers Behavioral Val R5
Price$86.07
Change+$0.94 (+1.10%)
VolumeN/A
Net Assets9.84B
PSOAX vs UBVVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PSOAX vs. UBVVX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSOAX is a StrongBuy and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.84B vs. PSOAX (1.25B). UBVVX pays higher dividends than PSOAX: UBVVX (1.77) vs PSOAX (0.79). PSOAX was incepted earlier than UBVVX: PSOAX (31 years) vs UBVVX (9 years). PSOAX (1.28) is less costly to investors than UBVVX (0.95). PSOAX is a more actively managed with annual turnover of: 61.00 vs. UBVVX (27.00). UBVVX has a lower initial minimum investment than PSOAX: UBVVX (0) vs PSOAX (1000). PSOAX annual gain was more profitable for investors over the last year : 0.44 vs. UBVVX (0.31). UBVVX return over 5 years is better than : 107.51 vs. PSOAX (48.69).
PSOAXUBVVXPSOAX / UBVVX
Total Expense Ratio1.190.90132%
Annual Report Gross Expense Ratio1.280.95135%
Fund Existence31 years9 years-
Gain YTD6.9402.489279%
Front Load5%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B9.84B13%
Annual Yield % from dividends0.791.7745%
Returns for 1 year0.440.31144%
Returns for 3 years21.6322.7595%
Returns for 5 years48.69107.5145%
Returns for 10 years19.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBGPF0.900.04
+5.01%
MOBERG PHARMA AB
AKRBF26.750.25
+0.94%
Aker BP Asa
HEHSF6.70N/A
N/A
Hellenic Stock Exchanges
HAPVD10.01N/A
N/A
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA
BDCC0.05N/A
-1.96%
Blackwell 3D Construction Corp.